MarketBeat on MSN11h
What Does the Future Hold for Eli Lilly?
GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...
The i on MSN14h
How to spot fake weight-loss jabs – and what they could do to your body
“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...